U.S. drug company Merck to share license for experimental covid-19 treatment with nonprofit organization But, according to Brook Baker, a professor of law at Northeastern University who has tracked the negotiations over the drug, the price of a course of treatment could fall below $10 as competition increases among manufacturers and production scale grows.